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Aims

Investigate haemodynamic effects, and their mechanisms, of restoring atrioventricular (AV)-coupling using pacemaker therapy in normal and failing hearts in a combined computational–experimental–clinical study.

...................................................................................................................................................................................................
Methods
Computer simulations were performed in the CircAdapt model of the normal and failing human heart and circulaand results
tion. Experiments were performed in a porcine model of AV dromotropathy. In a proof-of-principle clinical study,
left ventricular (LV) pressure and volume were measured in 22 heart failure (HF) patients (LV ejection fraction
<35%) with prolonged PR interval (>230 ms) and narrow or non-left bundle branch block QRS complex.
Computer simulations and animal studies in normal hearts showed that restoring of AV-coupling with unchanged
ventricular activation sequence significantly increased LV filling, mean arterial pressure, and cardiac output by 10–
15%. In computer simulations of failing hearts and in HF patients, reducing PR interval by biventricular (BiV) pacing
(patients: from 300 ± 61 to 137 ± 30 ms) resulted in significant increases in LV stroke volume and stroke work
(patients: 34 ± 40% and 26 ± 31%, respectively). However, worsening of ventricular dyssynchrony by using right
ventricular (RV) pacing abrogated the benefit of restoring AV-coupling. In model simulations, animals and patients,
the increase of LV filling and associated improvement of LV pump function coincided with both larger mitral inflow
(E- and A-wave area) and reduction of diastolic mitral regurgitation.

...................................................................................................................................................................................................
Conclusion
Restoration of AV-coupling by BiV pacing in normal and failing hearts with prolonged AV conduction leads to con-

siderable haemodynamic improvement. These results indicate that BiV or physiological pacing, but not RV pacing,
may improve cardiac function in patients with HF and prolonged PR interval.
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Graphical Abstract

Haemodynamics

What’s new?
• Normalizing atrioventricular (AV) coupling using biventricular
pacing in conditions of prolonged AV conduction times
improves left ventricular pump function significantly, both in
normal animal hearts and in failing human hearts.
• Increasing ventricular dyssynchrony by right ventricular pacing
attenuates the beneficial effect of normalizing AV-coupling.
• Normalizing AV-coupling creates its haemodynamic benefit by
both reducing diastolic mitral regurgitation and increasing
mitral inflow.
• The similarity of the preclinical and clinical results with those
from the computer simulations indicates that the mechanism
of haemodynamic improvement by optimizing AV-delay can
be explained by the well-established physical and physiological
principles that are incorporated in the model, such as
conservation of energy, inertia of blood, and length-dependent
activation of myocytes.

Introduction
Atrioventricular (AV) conduction delay (or: AV dromotropathy), as
evidenced by a prolonged PR interval (>200 ms) on the electrocardiogram (ECG), is present in 15–51% of patients with heart failure
(HF) and increases the risk of poor clinical outcome.1 A few small
studies in the 1990s suggested that shortening the AV-delay by ventricular pacing could improve cardiac pump function.2,3 These studies
were among the first to use ventricular pacing as a treatment for HF.
Notably, these studies employed right ventricular (RV) pacing, because these were performed before the era of biventricular (BiV)
pacing. In subsequent years, the attention for treatment of a prolonged PR interval faded as it became overruled by cardiac resynchronization therapy (CRT). However, recent sub-analyses of clinical
trials investigating the benefit of CRT revitalized the interest in this
topic.4 While patients without left bundle branch block (LBBB) generally show little clinical improvement from CRT, a significant benefit
was observed in non-LBBB patients with prolonged PR interval.5
Similarly, in a sub-study of the ReThinQ trial, which investigated the
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Methods
Studies were performed in the CircAdapt computer model of the human
heart and circulation, in a porcine model of AV-block and in patients with
HF and a prolonged PR interval (PR interval >230 ms).

Computer simulations
Previously, CircAdapt simulations of electro-mechanical and haemodynamic interventricular and atrioventricular interactions have been extensively validated and applied under physiological and pathophysiological
conditions, including dyssynchronous HF and its treatment with pacing
therapy (see Supplementary material online). In the CircAdapt model, a
prolonged PR interval was simulated by increasing AV-delay from 150 ms
to 300 ms in the reference simulation of the normal human heart with
synchronous ventricular activation. Starting from this reference simulation, the following simulations were performed: (i) gradual shortening of
the AV-delay from 300 to 50 ms (in steps of 25 ms) with synchronous
ventricular activation (SYNC) and normal myocardial contractility, and
(ii) gradual shortening of the AV-delay in a simulation of HF (LVEF < 35%)
with synchronous ventricular activation and dyssynchronous ventricular
activation, resembling BiV and RV pacing. Cardiac output (CO), transmitral flow patterns, mean arterial pressure (MAP), and ventricular volumes
were obtained for all simulations. More methodological details about the
model simulations are provided as Supplementary material online.

Animal experiments
Animal handling was performed in compliance with the Guide for the
Care and Use of Laboratory Animals and in accordance with the
European Community recommendations. The protocol was approved by
the Dutch National Ethical Committee for Animal Handling.
Experiments were performed in seven female landrace pigs weighing
61 ± 3 kg. Animals were pre-medicated with intramuscular Zoletil (5 mg/
kg). After induction with intravenous sodium thiopental (5–15 mg/kg), anaesthesia was maintained by continuous infusion of Propofol (10 mg/kg/
h), Sufentanyl (5 mg/kg/h), and Rocuronium (0.1 mg/kg/h). Details of the
experimental model are provided in Figure 1. Complete AV-block was
created by radiofrequency ablation of the AV-node. Subsequently, the
animals were paced at the right atrial appendage and at the RV apex and
left ventricular (LV) epicardial lateral wall. A 7-Fr conductance catheter
(CD Leycom, Zoetermeer, The Netherlands) was introduced into the

LV cavity via the femoral artery. A 4F Millar Mikro-Tip pressure catheter
(Millar, Houston, TX, USA) was used to measure left atrial (LA) pressure.
A vascular flow probe (Transonic Europe B.V., Elsloo, The Netherlands)
was mounted around the ascending aorta to asses aortic flow and subsequently calculate CO. Measurements were performed after instrumentation and haemodynamic stabilization using BiV pacing at 10 b.p.m. above
intrinsic atrial rhythm with an AV-delay of 300 ms, mimicking prolonged
PR interval, as baseline condition. Subsequently, during BiV pacing the
AV-delay was programmed between 50 and 250 ms in randomized steps
of 50 ms. Baseline recordings were performed before every step. Each recording lasted for at least two respiratory cycles.

Patient studies
The patient study was performed according to the principles of the
Declaration of Helsinki and the study protocol was approved by the
ethics committee of the Maastricht University Medical Centerþ (registration number NL60764.068.17/METC 171013). All patients gave written
informed consent prior to investigation, and the study was monitored by
the Clinical Trial Center Maastricht. The study has been registered at clinicaltrials.gov (https://clinicaltrials.gov/ct2/show/NCT03973944).
Patients were included in the Maastricht University Medical Centerþ
(n ¼ 20), the University Medical Center Utrecht (n ¼ 5), and the
Amsterdam University Medical Center (n ¼ 1) from June 2018 to
February 2020. Inclusion criteria were the presence of sinus rhythm, stable prolonged PR interval >230 ms, LV ejection fraction (LVEF) <35%,
New York Heart Association (NYHA) functional class II to III, optimal HF
medication, and indication for an implantable cardioverter-defibrillator
(ICD). Patients were implanted with a CRT-D and LV lead for this study,
considering that this additional implantation creates minimal additional
risk to the patient while the option to provide CRT therapy was offered
after the haemodynamic data of this study showed significant improvement. Patients were excluded when they already had a CRT device, in the
presence of a class I CRT indication (LBBB or QRS duration >150 ms).
Also, a resting heart rate >90 b.p.m., chronic renal failure requiring dialysis, moderate to severe aortic stenosis, frequent premature ventricular
complexes (>_two complexes on a standard ECG), significant peripheral
vascular disease, age below 18 years or recent (<3 months) myocardial
infarction, coronary artery bypass graft, or valve surgery were exclusion
criteria.
All participants underwent CRT device implantation according to routine clinical practice. The atrial lead was positioned in the right atrial appendage, the RV lead in the RV apical septum, and a quadripolar LV lead
in a suitable vein on the posterolateral LV wall. A 7-Fr pressure–volume
loop conductance catheter (CD Leycom, Zoetermeer, The Netherlands)
was introduced into the LV cavity via the femoral artery.
The ECG and LV pressure and volume were recorded during BiV and
RV pacing at four paced AV-delays. The paced AV-delay was set to
100%, 75%, 50%, and 25% of patient’s PR interval during baseline AAI
pacing 30 ms to ensure capture at the longest AV-delay.8 The pacing
protocol (in DDD mode) was performed at ±10 b.p.m. above intrinsic sinus rate. Interventricular pacing delay was set to 40 ms (LV first).
Baseline measurements were performed during atrial pacing (AAI mode)
at the same pacing rate before and after each mode of ventricular pacing.
Pressure–volume loops were recorded for 60 s during the ventricular
pacing protocol and 30 s before and after each setting in AAI mode. The
latter were averaged and are referred to as baseline.

Data analysis
The acute haemodynamic effect of pacing at the different AV-delays in
animals and patients was evaluated by invasive measurement of LV stroke
volume and stroke work (area of the pressure–volume loop) as well as
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benefit of CRT in patients with QRS duration <130 ms, only patients
with a prolonged PR interval (>180 ms) showed a significant increase
in maximum oxygen uptake.6 The 2021 ESC guidelines on pacing and
CRT recommend the use of pacing in patients with a PR interval
>300 (Class II1, Level C) without recommending a pacing site .7
Therefore, we hypothesized that restoring proper AV-coupling by
pacing significantly improves cardiac pump function. We investigated
this hypothesis and revealed the mechanisms of action using a threestep approach. First, the haemodynamic benefits of restoring AVcoupling were studied in a porcine model and a computational model
of the non-failing heart with prolonged PR interval. Second, the confounding effect of pacing-induced ventricular dyssynchrony and HF
on the potential haemodynamic benefit of restoring AV-coupling was
studied in the computational model. Third, a proof-of-principle clinical study was performed in patients with HF and a prolonged PR interval. In this study, a cut-off value for prolonged PR interval of
230 ms was chosen based on the subanalysis of the MADIT-CRT
study.5

F.C.W.M. Salden et al.
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the diastolic flow pattern, derived from the first derivative of the LV volume signal (flow; right panel of Figure 1) using a combination of the
Conduct NT software (CD Leycom, Zoetermeer, The Netherlands) and
customized software programmed in MATLAB R2019b (MathWorks,
Natick, MA, USA). Diastolic mitral regurgitation (MR) volume was quantified as the area below zero of the flow curve during diastole. Forward
flow over the mitral valve was quantified as the combined area under the
E- and A-waves (see also Figures 1 and 2). The diastolic MR fraction was
defined as diastolic MR as a percentage of forward flow. In the animals,
stroke volume was derived from the aortic flow probe. To account for
spontaneous changes in baseline haemodynamic outcome parameters,
each ventricular pacing setting was compared with the corresponding
baseline. Ectopic ventricular beats and the two subsequent heart beats
were excluded from the analysis. Conductance catheter measurements
were volume calibrated by adjusting baseline stroke volume to stroke
volume measured using Swan Ganz thermodilution catheters in animals
and to pre-procedural echocardiography in patients.

Statistical analysis of clinical and experimental study
Statistical analysis was performed using Statistical Package for Social
Sciences version 24.0 (SPSS Inc., Chicago, IL, USA). Continuous data are
presented as mean ± standard deviation (SD). The relative change of the
haemodynamic variables at various AV-delays was evaluated using a oneway repeated measures ANOVA. If significant, a Student’s paired samples
T-test and Bonferroni correction was used to test significance of the
change at individual AV-delays. To evaluate differences between different
pacing modes, two-way ANOVA for repeated measurements was used,

followed by Student’s paired samples T-test. A two-sided probability
value of <0.05 was considered statistically significant.

Results
Restoring atrioventricular-coupling in
normal hearts: animal experimental and
computational analyses
Results from animal experiments and computer simulations showed
good qualitative and quantitative agreement (Figure 2). Under baseline conditions at long AV-delay, the delay of ventricular activation
resulted in (i) suboptimal LV filling with the early filling wave (E) being
fused with or prematurely interrupted by the atrial filling wave (A),
and (ii) diastolic MR due to atrial relaxation and related atrial pressure
drop occurring before the onset of ventricular activation and, hence,
papillary muscle contraction. At intermediate AV-delays (150 ms)
separated E- and A-waves were observed. At short AV-delays, Awave truncation occurred as well as increases in peak and mean LA
pressure, presumably caused by atrial contraction against a closed mitral valve.
Figure 3 depicts that in the computer simulations and the animal
studies, the largest increase in LV end-diastolic volume was observed
at the AV-delay leading to the LV filling pattern with most pronounced E–A wave separation (175 ms in the simulations, 157 ± 7 ms
in the animals) and leading to minimal diastolic MR. At this setting,
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Figure 1 Schematic representation of the animal experimental set-up. (A) Overview of the porcine model. Pacemaker leads were transvenously
inserted in the right atrial (RA) appendage and right ventricular (RV) apex and attached to the left ventricular (LV) epicardium. Complete atrioventricular (AV) block was created by radiofrequency ablation of the AV-node. The LV pressure and volume were measured using a conductance catheter
and RV and left atrial (LA) pressure were measured using a cathetertip manometer. (B) Signal analysis. The first derivative of LV volume was used to
calculate forward flow over the mitral valve (blue area under E and A wave) and diastolic mitral regurgitation (MR, red area). The integral of aortic
flow, measured by a flow probe, was used to quantify forward stroke volume and cardiac output (purple area).
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MAP and CO were also increased (both 15% in simulations and
10% in animals). Importantly, in the animal studies, the largest increase in LVEDV (at AV-delay 150 ms) was achieved without a significant change in mean LA pressure compared with the baseline
condition with long AV-delay (Table 1).
Both the computer simulations and animal studies showed that the
increased filling at intermediate AV-delays was achieved by a dual effect: larger forward flow over the mitral valve (area under the E- and
A-waves) and reduction in diastolic MR (central figure, Table 1).

haemodynamic response to changes of AV-coupling in the failing
heart. The amount of haemodynamic improvement obtained with recovery of AV-coupling depended on the degree of pacing-induced
ventricular dyssynchrony. The largest haemodynamic improvement
was predicted with the simulations with synchronous ventricular activation, while RV pacing simulations showed the smallest improvement, in terms of stroke volume (Figure 4A), LVEDV (Figure 4B), and
LV inflow pattern (Figure 4C). Most separated E- and A-waves and
least diastolic MR occurred during synchronous pacing (Figure 4C).

Modulating effects of ventricular
dyssynchrony: computer simulations

Patient study

While the aforementioned study results concerned manipulation of
AV-coupling in normal hearts at a constant degree of ventricular dyssynchrony, a next step was to investigate how different degrees of
pacing-induced ventricular dyssynchrony would influence the

Table S1 ( see Supplementary material online) shows the baseline patient characteristics. The study cohort consisted of patients with
moderate to severe HF (NYHA II or III), mean LVEF of 29 ± 6%,
mean PR interval of 261 ± 32 ms, QRS duration of 123 ± 19 ms, and a
mix of ischaemic and dilated cardiomyopathy.
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Figure 2 Haemodynamic effect of improving atrioventricular (AV)-coupling in pig experiments and computer simulations during biventricular pacing. (Top row) LV and LA pressures, (second row) flow, and (third row) ECG from a representative experiment. (Fourth and fifth row) Pressures
and flow calculated from computer simulations.
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Table 1

Haemodynamic data of AV-optimization in porcine hearts during BiV pacing
AV-delay

.................................................................................................................................................................
50 ms

100 ms

150 ms

200 ms

250 ms

300 ms (BL)

....................................................................................................................................................................................................................
PQ interval (ms)
MAP (mmHg)
Cardiac output aorta (l/min)

53 ± 2*

102 ± 2*
*

79 ± 25
3.0 ± 0.3

151 ± 1*

202 ± 2*
*

87 ± 23
3.3 ± 0.3

91 ± 24
3.4 ± 0.4

254 ± 2*
*

91 ± 23
3.4 ± 0.4

88 ± 25
3.2 ± 0.3

304 ± 1
84 ± 24
3.1 ± 0.3

Stroke work (mmHgmL)

3732 ± 1146

4316 ± 1012

4437 ± 1042

4379 ± 1123

4169 ± 1239

3828 ± 1266

LV dP/dtmax (mmHg/s)
LV SP (mmHg)

1225 ± 311*
95 ± 21*

1297 ± 282
102 ± 20

1274 ± 259
106 ± 22*

1308 ± 282
105 ± 21*

1275 ± 295
103 ± 22

1265 ± 311
99 ± 21

7.0 ± 2.8

8.7 ± 2.6

LV EDP (mmHg)

*

7.8 ± 2.4
83 ± 39

*

9.5 ± 2.1*

7.8 ± 2.4

7.4 ± 2.9*

6.9 ± 3.0

6.8 ± 2.3
90 ± 36*

6.6 ± 2.2
87 ± 36*

6.6 ± 2.4
83 ± 39*

6.5 ± 2.2
80 ± 40

LAPmean (mmHg)
LV EDV (mL)

8.4 ± 2.4
78 ± 39

Diastolic MR (mL/beat)

0.3 ± 0.5

2.5 ± 1.9

4.4 ± 2.9

4.5 ± 3.3

4.3 ± 3.3

6.1 ± 4.0

Forward flow (mL/beat)
MR fraction (%-point)

50 ± 9
0.9 ± 1.5

53 ± 8
5.2 ± 4

53 ± 6
9.5 ± 6.2

53 ± 6
10 ± 7.2

51 ± 7
10 ± 7.7

51 ± 8
15 ± 10.2

Results are presented as mean ± SD (n = 7).
BL, baseline; EDP, end diastolic pressure; EDV, end diastolic volume; ESV, end systolic volume; LAPmean, mean left atrial pressure; LV, left ventricular; LVSP, LV systolic pressure;
MAP, mean arterial pressure; MR, mitral regurgitation.
*P < 0.05 compared with 300 ms (BL) using one-way repeated measures ANOVA followed by Student’s paired samples T-test and Bonferroni correction.

Similar to the computer simulations and animal studies (Figures 2
and 4), patients showed the characteristic pattern of E–A wave fusion
and diastolic MR at baseline (Figure 5A). During BiV pacing, a clear
separation of the E- and A-waves was seen at AV-delays of 50% and
75% of intrinsic PR interval, while truncation of the A-wave occurred
at shorter AV-delay (25% of intrinsic PR interval). Restoration of

AV-coupling by BiV pacing at an AV-delay of 50% of intrinsic PR interval (137 ± 30 ms) resulted in a significant increase of forward mitral
flow (on average þ8mL/beat) and reduction of MR fraction (on average 12%-point), Figure 5B and C, Table 2.
Figure 6A presents LV pressure–volume loops of a patient during
BiV (left) and RV pacing (right). When compared with baseline, BiV
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Figure 3 Haemodynamic response to improving atrioventricular (AV) coupling in pig experiments and computer simulations during biventricular
pacing. Relative changes in haemodynamic function by shortening AV-delay in all pig experiments (top panel) and simulations (bottom panel) when
compared with a baseline PR interval of 300 ms. For the pig experiments mean±SD are presented. * indicates P < 0.05 when compared with baseline.
MAP, mean arterial pressure; LAPmean, mean left atrial pressure; LVEDV, left ventricular end diastolic volume.
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A

C

Figure 4 Effect of interventricular desynchronization on haemodynamic benefits of restoring AV-coupling. Simulation data from the protocol
where restoration of AV-coupling was achieved with unchanged synchronous ventricular activation (red) or with biventricular (BiV) pacing (orange)
or right ventricular (RV) pacing (purple). (A) Change in stroke volume. (B) Pressure volume loops at optimal pump function. (C) Mitral valve flow.

pacing increased LV stroke volume and stroke work (width and area
of the loop, respectively), with the most pronounced benefit at an
AV-delay of 50% of intrinsic PR interval. In contrast, RV pacing tend
to reduce stroke volume and stroke work, particularly at shorter
AV-delays. It can also be observed that peak LV pressure diminished
during RV pacing.
In the entire cohort of patients, BiV pacing increased QRS duration
moderately, whereas a more pronounced prolongation occurred by
applying RV pacing (Table 2). BiV pacing at an AV-delay of 50% of intrinsic PR interval significantly increased LV stroke volume by
34 ± 40% (Figure 6B) and LV stroke work by 26 ± 31% (Figure 6C),
when compared with baseline. The increase in LV stroke work provided by BiV pacing coincided with slight but significant increases in
LV end-diastolic pressure (on average 2 mmHg) and LV dP/dtmax and
largely unchanged systolic LV pressure (Table 2). In contrast,

restoration of the AV-delay with RV pacing did not change or even
decreased stroke volume and stroke work compared with baseline
(Table 2). The decrease in stroke work during RV pacing at short AVdelays coincided with significant reductions in stroke volume, systolic
LV pressure, and LV dP/dtmax (Table 2).

Discussion
The presented combination of computational, experimental, and clinical proof-of-principle studies provides strong evidence that restoration of AV-coupling by BiV pacing results in significant haemodynamic
benefit in hearts with AV dromotropathy (evidenced by a prolonged
PR interval). This benefit is caused by (i) increased ventricular filling,
established by a larger forward flow across the mitral valve and less

Downloaded from https://academic.oup.com/europace/article/24/5/784/6413939 by Washington University School of Medicine Library (M2) user on 28 December 2022
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A

C

Figure 5 Haemodynamic effect of improving atrioventricular (AV)-coupling in patients. (A) Left ventricular (LV) pressure (Top row) and flow
(Second row) and ECG (third row), as measured in a representative patient. Diastolic mitral regurgitation (MR) is presented in red. Absolute changes
in (B) diastolic mitral forward flow, and (C) diastolic mitral regurgitant (MR) fraction when compared with baseline (AAI) in the entire cohort. In the
ECG an atrial pacing spike is present in all conditions, in the biventricular paced beats the LV pacing spike is indicted by a large vertical bar which is followed 40 ms later by a small spike representing the RV stimulus. Mean ± SD are presented. *P < 0.05 when compared with baseline.

late-diastolic MR, but (ii) is attenuated by ventricular desynchronization due to RV pacing. These results indicate that the current guidelines on pacing and CRT 7 may need revision, because the lower limit
of PR interval for recommending pacing therapy may be decreased
(from >300 to >230 ms) and that BiV pacing is recommended. In order to avoid ventricular desynchronization, besides BiV pacing, also
recently proposed modes of physiological ventricular pacing, such as
His bundle, left bundle branch, and LV septum pacing9,10 may be used
to this purpose.

Restoring atrioventricular coupling
provides haemodynamic improvement
A few studies in the 1990s used DDD RV pacing to restore AV-coupling.2,3 These studies showed beneficial effects of normalization of
AV-coupling in terms of reduction of diastolic MR,2 longer filling

times and larger CO2, and higher LVEF and arterial blood pressure.3
Notably, these studies were performed in small (12–24 patients)
cohorts with variable baseline characteristics (wide and narrow QRS
complex, normal, and depressed cardiac function). The results from
the present study not only corroborate these findings using state-ofthe-art measurements, but also extend them and provide a comprehensive understanding of mechanisms involved. The complicated interaction between (intrinsic or paced) AV-delay and ventricular
dyssynchrony on haemodynamics may explain why other (unpublished) studies were not able to reproduce these results, in particular
when single site pacing was used.
Improving AV-coupling is an integral part of ‘conventional CRT’ in
patients with LBBB and/or QRS duration >150 ms (class I CRT indication) and its benefit can therefore be considered as evidence-based.
Interestingly, recent analysis using the same computer model as used
in the present study, and data from CRT patients indicated that
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Table 2 Haemodynamic and electrocardiographic data in patients paced at various paced AV-delays (% of intrinsic PR
interval—30 ms)

........................................................................................................................................................
25%

50%

75%

100%

AAI

....................................................................................................................................................................................................................
BiV pacing

Baseline

AV-delay (ms)
QRS duration (ms)

70 ± 14*
147 ± 24*,**

137 ± 30*
149 ± 22*,**

203 ± 40*
142 ± 22**

270 ± 51*
129 ± 29

300 ± 61
128 ± 25

LVPmax (mmHg)

110 ± 22*

115 ± 23

117 ± 24

117 ± 25

118 ± 25

Stroke volume (mL)
Stroke work (mLmmHg)
LV dP/dtmax (mmHg/s)
LV EDP (mmHg)
LV EDV (mL)
Diastolic forward flow (mL/beat)

53 ± 19**
4993 ± 2041**

58 ± 20*,**
5605 ± 2263*,**

59 ± 21*
5726 ± 2369*

53 ± 18*
5273 ± 2128*

48 ± 16
4792 ± 1992

896 ± 164**

935 ± 153**

965 ± 162**

971 ± 165*

927 ± 166

11 ± 7
213 ± 55

11 ± 6
215 ± 56

11 ± 5
208 ± 55
65 ± 22**
*

*

*

13 ± 8
215 ± 59

13 ± 6
215 ± 56
69 ± 23*,**

68 ± 22*

*

66 ± 21*

61 ± 21

9±9
429 ± 111

12 ± 9*
415 ± 93

137 ± 30
173 ± 20*

203 ± 40
165 ± 22*

270 ± 51
143 ± 25

300 ± 61
128 ± 25

109 ± 19*

115 ± 22

118 ± 24

120 ± 24

118 ± 25

42 ± 17
3885 ± 1844*

46 ± 19
4455 ± 2055

48 ± 19
4811 ± 2254

48 ± 18
4904 ± 2090

48 ± 16
4792 ± 1992

LV dP/dtmax (mmHg/s)

801 ± 145*

845 ± 144*

896 ± 163

951 ± 148

927 ± 166

LV EDP (mmHg)
LV EDV (mL)

11 ± 7
213 ± 51

12 ± 7
220 ± 55

13 ± 7*
222 ± 56

11 ± 6
219 ± 51

11 ± 6
215 ± 56

55 ± 22
13 ± 12

59 ± 23
11 ± 9

61 ± 24
14 ± 10

62 ± 24
17 ± 10

61 ± 21
18 ± 11

416 ± 99

409 ± 91

411 ± 95

414 ± 101

417 ± 87

MR fraction (%)
Diastolic filling time (ms)

9±9
434 ± 104*

6±6
432 ± 104

AV-delay (ms)
QRS duration (ms)

70 ± 14
175 ± 20*

LVPmax (mmHg)

*

RV pacing

Stroke volume (mL)
Stroke work (mLmmHg)

Diastolic forward flow (mL/beat)
MR fraction (%-point)
Diastolic filling time (ms)

18 ± 11
417 ± 87
Baseline

Results are presented as mean±SD (n = 22).
BiV, biventricular; AV, atrioventricular; LV, left ventricular; EDP, end diastolic pressure; EDV, end diastolic volume; MR, mitral regurgitation; RV, right ventricular.
*P < 0.05 compared with baseline.
**P < 0.05 compared with RV pacing with corresponding AV-delay, using one- and two-way repeated measures ANOVA, respectively, followed by Student’s paired samples Ttest and Bonferroni correction.

improving AV-coupling in ‘conventional’ CRT may be responsible for
more than two-thirds of the benefit of this therapy while only onethird was accounted for by ventricular resynchronization.11
However, the feasibility, safety, and long-term efficacy of pacingbased AV-coupling in patients without LBBB and with narrow QRS
complex requires further investigation in prospective clinical trials.
Such studies should also provide a more precise definition of the category patients that qualify for this therapy, such as the optimal cut-off
of PR interval, degree of separation of E and A wave on the mitral
valve Doppler velocity recording, NYHA class, ischaemic or nonischaemic cardiomyopathy, and LVEF. In addition, duration of the (intrinsic and paced) P-wave may be important to take into account, because large inter-atrial delay may safeguard LV filling in the presence
of a long PR interval.

Haemodynamic improvement relates to
better ventricular filling
The crucial finding of the present study is that improving AV-coupling
leads to increased LV filling, thereby increasing CO at unchanged

(patients) or increased (simulations, animals) blood pressure. These
improvements are likely explained by the length-dependent activation of the myocardium, the cellular basis of the well-known Frank–
Starling mechanism. Notably, LV dP/dtmax was hardly affected,
whereas this is a very sensitive marker of CRT benefit in LBBB
patients.8,12 Yet, the overall haemodynamic benefit of AV-coupling in
terms of CO seems at least as large as that of ‘CRT’. Increases in
stroke work, measured in this study using the conductance catheter
technique, were on average slightly smaller than those measured during conventional CRT (28 vs. 43%).13 However, this difference may
be due to very small pressure–volume loop areas in LBBB hearts that
may be associated with an artefact of the conductance catheter technique. Another important finding is that the increased LV filling during
optimal AV-coupling is achieved by both improved diastolic filling pattern (i.e. larger and better separated E- and A-waves) and less diastolic MR. Finally, an important finding from the animal and simulation
studies was that the improved filling was achieved while mean LA
pressure was equal to or lower than baseline, indicating that the better forward pump function may even coincide with reduced backward failure.

Downloaded from https://academic.oup.com/europace/article/24/5/784/6413939 by Washington University School of Medicine Library (M2) user on 28 December 2022

AV-delay (5PR 30 ms)

793

Biventricular pacing improves haemodynamics in prolonged PR interval

(A) Left ventricular (LV) pressure–volume loops in a representative patient at baseline (dashed line) and at tested AV-delay settings (solid lines) during
BiV pacing (left) and right ventricular pacing (right). Relative changes in stroke volume (B) and stroke work (C) when compared with baseline (AAI)
for BiV (black) and RV pacing (grey) in the entire cohort. Mean ± SD are presented. *P < 0.05 when compared with baseline.

In the past, several studies have shown similar results concerning
parts of the parameters investigated in the present study. The importance of proper AV-coupling has already been addressed by animal
studies in the 1960s,14 reporting that a properly timed effective atrial
contraction is necessary for optimal LV systolic function. Similar findings were obtained in a small clinical study where echo-Doppler as
well as invasive pressure and flow measurements were used. In eight
patients with PR intervals >200 ms, AV-optimization using DDD RV
pacing increased filling times, LV end-diastolic pressure, and CO.15
Other clinical studies showed echo-Doppler recordings of mitral Eand A-waves with A-wave truncation at too short AV-delays and E–Awave fusion combined with diastolic MR at too long AV-delays.16,17
The results from the present study provide the full picture with
comprehensive invasive haemodynamic measurements in animals
and patients, supplemented by computer simulations that enable
control of experimental conditions that cannot be achieved in vivo
(like disabled MR). Furthermore, the use of the first derivative of the
LV volume signal of the conductance catheter provides diastolic ventricular inflow patterns, rather than velocities as is the case in echoDoppler studies. Therefore, the forward and backward flows, determined in the present study, represent the actual blood volume
displaced.

The fact that the computer model could replicate all the changes
seen in the animals, indicates that the mechanism of haemodynamic
improvement by optimizing AV-delay can be explained by the wellestablished physical and physiological principles that are incorporated
in the model, such as conservation of energy, inertia of blood, and
length-dependent activation of myocytes (Frank–Starling effect).

Effects of ventricular pacing-induced
dyssynchrony
The RV pacing is known to increase ventricular dyssynchrony and
thereby to have a negative impact on cardiac pump function.18 Our
patient and simulation data show that the benefit of normalizing AVcoupling should be weighed against the detrimental effect of pacinginduced ventricular dyssynchrony. In the present study, BiV pacing
was able to acutely increase cardiac pump function in 19 out of 22
patients, indicating that the functional gain achieved by improving AVcoupling is relatively large compared with the loss of function due to
BiV pacing-induced ventricular dyssynchrony. On the other hand, severe ventricular dyssynchrony occurs during RV pacing abrogates the
haemodynamic benefits of restoring AV-coupling. Interestingly,
shortening the AV-delay using RV pacing did not improve filling either, due to a lack of reduction in diastolic MR and no increase in
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Limitations
The present patient study has all the characteristics of a proof-ofprinciple study, showing acute haemodynamic effects in a small cohort. For ethical reasons, patients in this study all had the indication
for ICD implant, so that the implant of the LV lead was only a minor
extension of the medically indicated procedure. Clearly, studies in a
wider population (also non-ICD indicated patients) and using longterm outcome as endpoint are required to provide further evidence
for the benefit of improving AV-coupling in patients with a prolonged
PR interval. Promising is that subanalyses in non-LBBB patients of the
randomized MADIT-CRT20 and RethinQ6 trials also indicate that
patients with long PR interval can benefit from BiV pacing when compared with their unpaced ‘control group’ counterparts.
The preclinical studies were performed in porcine hearts. While
this species is frequently used for cardiovascular research, a limitation
is that the amount of dyssynchrony induced by (single site) ventricular pacing is small. Therefore, for this study only BiV pacing was used
to demonstrate the effect of AV-coupling at unchanged ventricular
activation (BiV pacing being used for all AV-delays). Moreover, the
lack of intra-thoracic negative pressure in these open-thorax experiments may have interfered with the effect of AV-interval on filling.

Conclusions
The combination of computational, experimental, and clinical studies
provides strong confirmation of previous evidence that normalizing
AV-coupling by BiV pacing in hearts with prolonged PR interval
improves cardiac pump function. This improvement is predominantly
achieved by better ventricular filling, caused by a combined effect of
reduction in diastolic MR and increase in diastolic forward flow.
Pacing-induced ventricular dyssynchrony, caused by RV pacing,
attenuates the benefit of restored AV-coupling. Therefore, this study
may pave the way for a novel pacing-based therapeutic approach in
patients with HF and prolonged PR interval that is not part of current
guidelines.
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Fist in man implantation of a leadless pacemaker in the left atrial appendage
following Mustard repair
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Sinus node disease is common in atrial switch patients.
Transvenous and ventricular pacing can be problematic due to baffle stenosis and systemic right ventricular dysfunction, respectively.
We describe the implantation of MicraTM (Med
tronic, USA) leadless pacemakers in the left atrial
appendage of two patients previously treated with
atrial switch operations. The left atrium was accessed
via the left femoral vein using a 24-Fr DrysheathTM
(Gore, USA). A MicraTM (Medtronic, USA) device
was then implanted using the integrated delivery catheter (see Figure showing appendage injection and final
position). Acceptable parameters were achieved in
both cases (threshold 0.38 V at 0.24 ms, p 4.5 mV in one case, threshold 0.5 V @0.24 ms, p 1.9 mV in the other). Stability was tested using
standard manoeuvres. Clinical follow-up at 6 weeks has again shown excellent pacing parameters in both patients.
These are to our knowledge the first described cases of leadless pacemaker implant in the atrium. The morphology of the left atrial
appendage alongside the fact that it is readily accessed from the femoral vein makes leadless left atrial appendage pacing a feasible solution
for atrial switch patients who have sinus node disease in whom both transvenous and ventricular pacing are problematic.
The full-length version of this report can be viewed at: https://www.escardio.org/Education/E-Learning/Clinical-cases/Electrophysiology.
C The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
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